Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis

Gastroenterology

Volumn 149, Issue 2, 2015, Pages 398-406.e8

  Louvet, Alexandre ^a,b   Labreuche, Julien ^a   Artru, Florent ^a,b   Boursier, Jérôme ^c   Kim, Dong Joon ^d   O'Grady, John ^e   Trépo, Eric ^f   Nahon, Pierre ^g   Ganne Carrié, Nathalie ^g   Naveau, Sylvie ^h   Diaz, Emmanuel ⁱ   Gustot, Thierry ^f   Lassailly, Guillaume ^a,b   Cannesson Leroy, Amélie ^a,b   Canva Delcambre, Valérie ^a   Dharancy, Sébastien ^a,b   Park, Seung Ha ^j   Moreno, Christophe ^f   Morgan, Timothy R ^k   Duhamel, Alain ^a   Mathurin, Philippe ^a,b   more..

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d Hallym University College of Medicine   (South Korea)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ERASME HOSPITAL   (Belgium)

^g HÔPITAL JEAN VERDIER   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ Service d'Hépato Gastroentérologie ^*  (France)

^j Inje University College of Medicine   (South Korea)

^k VA LONG BEACH HEALTHCARE SYSTEM   (United States)

more..

Author keywords

AH; Cirrhosis; Classification; Prognostic Factor

Indexed keywords

CORTICOSTEROID; PENTOXIFYLLINE; PREDNISOLONE; BILIRUBIN; CREATININE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BELGIUM; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DYNAMICS; FEMALE; FRANCE; HUMAN; KOREA; LIVER DISEASE SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT RISK; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; AGING; BIOLOGICAL MODEL; BLOOD; GREAT BRITAIN; HEPATITIS, ALCOHOLIC; LIVER; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VALIDATION STUDY;

ADULT; AGING; BILIRUBIN; CREATININE; FEMALE; FRANCE; GREAT BRITAIN; HEPATITIS, ALCOHOLIC; HUMANS; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROGNOSIS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84938071194     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.04.044     Document Type: Article

References (23)

1. EASL clinical practical guidelines: management of alcoholic liver disease J Hepatol 57 2012 399 420
2. M. Dominguez, D. Rincon, J.G. Abraldes, and et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis Am J Gastroenterol 103 2008 2747 2756
3. W. Dunn, L.H. Jamil, L.S. Brown, and et al. MELD accurately predicts mortality in patients with alcoholic hepatitis Hepatology 41 2005 353 358
4. E.H. Forrest, C.D. Evans, S. Stewart, and et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score Gut 54 2005 1174 1179
5. W.C. Maddrey, J.K. Boitnott, M.S. Bedine, and et al. Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193 199
6. W. Srikureja, N.L. Kyulo, B.A. Runyon, and et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis J Hepatol 42 2005 700 706
7. A. Louvet, S. Naveau, M. Abdelnour, and et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
8. P. Mathurin, M. Abdelnour, M.J. Ramond, and et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone Hepatology 38 2003 1363 1369
9. P. Mathurin, J. O'Grady, R.L. Carithers, and et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 2011 255 260
10. M. Phillips, H. Curtis, B. Portmann, and et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis - A randomised clinical trial J Hepatol 44 2006 784 790
11. P. Mathurin, A. Louvet, A. Duhamel, and et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial JAMA 310 2013 1033 1041
12. C.L. Mendenhall, S. Anderson, P. Garcia-Pont, and et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone N Engl J Med 311 1984 1464 1470
13. S.H. Park, D.J. Kim, Y.S. Kim, and et al. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial J Hepatol 61 2014 792 798
14. R.L. Carithers Jr., H.F. Herlong, A.M. Diehl, and et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial Ann Intern Med 110 1989 685 690
15. M.R. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
16. P. Bedossa, T. Poynard, S. Naveau, and et al. Observer variation in assessment of liver biopsies of alcoholic patients Alcohol Clin Exp Res 12 1988 173 178
17. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
18. J.F. Harrell %daspline.sas 1991 Mayo Foundations for Medical Education and Research Rochester, MN
19. D. Schoenfeld Partial residuals for the proportional hazards regression model Biometrika 69 1982 239 241
20. P. Royston, K.G. Moons, D.G. Altman, and et al. Prognosis and prognostic research: developing a prognostic model BMJ 338 2009 b604
21. P. Royston, and D.G. Altman External validation of a Cox prognostic model: principles and methods BMC Med Res Methodol 13 2013 33
22. H. Akaike A new look at the statistical model identification IEEE Trans Autom Contr CA19 1974 716 723
23. H. Uno, T. Cai, M.J. Pencina, and et al. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data Stat Med 30 2011 1105 1117